Cargando…
Evolving Management Strategies for Metastatic Esophageal and Gastroesophageal Junction Adenocarcinoma
Metastatic or unresectable esophageal and gastroesophageal junction adenocarcinoma represent a devastating disease with 5-year survival rate of <5%. Although cytotoxic chemotherapy with platinum-doublet-based regimens is initially effective, patients inevitably progress. Patients often decline ra...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527138/ https://www.ncbi.nlm.nih.gov/pubmed/31119034 http://dx.doi.org/10.17925/OHR.2018.14.2.82 |